NASDAQ:ADXS
$2.10
(
-0.474%
)
Friday, 3rd Feb 2023
Advaxis Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.10 | $3.75 | Friday, 3rd Feb 2023 ADXS stock ended at $2.10. This is 0.474% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 7.46% from a day low at $2.01 to a day high of $2.16. |
| 90 days | $1.00 | $3.75 | |
| 52 weeks | $0.0550 | $4.50 |
Historical Advaxis prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $2.11 | $2.16 | $2.01 | $2.10 | 6 336 |
| 2023-02-02 | $2.08 | $2.16 | $2.07 | $2.11 | 5 388 |
| 2023-02-01 | $2.05 | $2.48 | $2.00 | $2.17 | 9 492 |
| 2023-01-31 | $2.25 | $2.42 | $1.95 | $2.30 | 12 977 |
| 2023-01-30 | $2.25 | $2.25 | $1.75 | $1.90 | 12 528 |
| 2023-01-27 | $2.36 | $2.40 | $2.20 | $2.40 | 4 708 |
| 2023-01-26 | $2.40 | $2.42 | $2.35 | $2.36 | 3 866 |
| 2023-01-25 | $2.41 | $2.70 | $2.25 | $2.41 | 13 218 |
| 2023-01-24 | $2.59 | $2.59 | $2.41 | $2.41 | 19 949 |
| 2023-01-23 | $2.40 | $2.78 | $2.27 | $2.39 | 13 947 |
| 2023-01-20 | $2.56 | $3.25 | $2.28 | $2.85 | 20 027 |
| 2023-01-19 | $3.13 | $3.13 | $2.56 | $2.60 | 4 548 |
| 2023-01-18 | $2.22 | $3.75 | $2.22 | $2.95 | 30 391 |
| 2023-01-17 | $1.70 | $2.39 | $1.70 | $2.22 | 21 521 |
| 2023-01-13 | $1.45 | $1.98 | $1.45 | $1.60 | 2 636 |
| 2023-01-12 | $1.65 | $1.77 | $1.44 | $1.60 | 16 011 |
| 2023-01-11 | $1.48 | $1.60 | $1.35 | $1.50 | 9 963 |
| 2023-01-10 | $1.31 | $1.47 | $1.16 | $1.35 | 3 776 |
| 2023-01-09 | $1.33 | $1.33 | $1.33 | $1.33 | 604 |
| 2023-01-06 | $1.25 | $1.35 | $1.10 | $1.35 | 2 061 |
| 2023-01-05 | $1.25 | $1.26 | $1.25 | $1.26 | 465 |
| 2023-01-04 | $1.25 | $1.25 | $1.25 | $1.25 | 373 |
| 2023-01-03 | $1.35 | $1.35 | $1.35 | $1.35 | 194 |
| 2022-12-30 | $1.18 | $1.30 | $1.15 | $1.20 | 15 885 |
| 2022-12-29 | $1.23 | $1.24 | $1.00 | $1.18 | 11 447 |
| 2022-12-28 | $1.05 | $1.32 | $1.00 | $1.18 | 7 813 |
| 2022-12-27 | $1.20 | $1.20 | $1.01 | $1.08 | 12 954 |
| 2022-12-23 | $1.30 | $1.30 | $1.22 | $1.22 | 4 166 |
| 2022-12-22 | $1.23 | $1.65 | $1.23 | $1.30 | 22 618 |
| 2022-12-21 | $1.28 | $1.35 | $1.28 | $1.29 | 1 512 |
| 2022-12-20 | $1.30 | $1.33 | $1.24 | $1.30 | 2 211 |
| 2022-12-19 | $1.22 | $1.36 | $1.22 | $1.35 | 5 276 |
| 2022-12-16 | $1.25 | $1.27 | $1.24 | $1.27 | 3 439 |
| 2022-12-15 | $1.35 | $1.40 | $1.20 | $1.20 | 1 226 |
| 2022-12-14 | $1.39 | $1.39 | $1.35 | $1.35 | 2 317 |
| 2022-12-13 | $1.35 | $1.57 | $1.35 | $1.36 | 1 274 |
| 2022-12-12 | $1.59 | $1.59 | $1.34 | $1.34 | 2 823 |
| 2022-12-09 | $1.49 | $1.65 | $1.49 | $1.62 | 3 669 |
| 2022-12-08 | $1.66 | $1.66 | $1.66 | $1.66 | 0 |
| 2022-12-07 | $1.66 | $1.66 | $1.66 | $1.66 | 0 |
| 2022-12-06 | $1.66 | $1.66 | $1.66 | $1.66 | 0 |
| 2022-12-05 | $1.66 | $1.66 | $1.66 | $1.66 | 0 |
| 2022-12-02 | $1.66 | $1.66 | $1.66 | $1.66 | 311 |
| 2022-12-01 | $1.68 | $1.68 | $1.55 | $1.67 | 4 112 |
| 2022-11-30 | $1.71 | $1.71 | $1.56 | $1.65 | 4 348 |
| 2022-11-29 | $1.66 | $1.71 | $1.65 | $1.71 | 4 966 |
| 2022-11-28 | $1.77 | $1.77 | $1.65 | $1.66 | 1 381 |
| 2022-11-25 | $1.65 | $1.70 | $1.65 | $1.70 | 835 |
| 2022-11-23 | $1.66 | $1.77 | $1.60 | $1.76 | 3 022 |
| 2022-11-22 | $1.66 | $1.71 | $1.65 | $1.71 | 3 299 |
About Advaxis
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
